Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Ermenegildo Zegna NV
ZGN
DexCom
DXCM
Workday
WDAY
(FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q2)Jan 31, 2024 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q2)Jan 31, 2023 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | (Q2)Jan 31, 2022 | (FY)Jul 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 67.60%389.92K | 67.60%389.92K | 74.74%425.04K | -84.12%232.66K | -84.12%232.66K | -77.48%243.24K | 13.10%1.46M | --1.46M | 0.01%1.08M | 1.18%1.3M |
-Cash and cash equivalents | 67.60%389.92K | 67.60%389.92K | 74.74%425.04K | -30.48%232.66K | -30.48%232.66K | 155,820.51%243.24K | 55.61%334.66K | --334.66K | --156 | --215.06K |
-Restricted cash and investments | ---- | ---- | ---- | ---- | ---- | ---- | 4.63%1.13M | --1.13M | 0.00%1.08M | -15.63%1.08M |
Receivables | 32.52%11.16M | 32.52%11.16M | 66.89%8.21M | 26.05%8.42M | 26.05%8.42M | 8.10%4.92M | -34.96%6.68M | --6.68M | -10.56%4.55M | 99.43%10.27M |
-Available for sale securities | -25.43%2.63M | -25.43%2.63M | -29.89%10.27M | --3.53M | --3.53M | --14.65M | ---- | ---- | ---- | ---- |
Other assets | -96.50%30.89K | -96.50%30.89K | 26.62%39.2K | 1,641.27%882.67K | 1,641.27%882.67K | -17.43%30.96K | -8.44%50.69K | --50.69K | -4.16%37.49K | 28.61%55.37K |
Total assets | 3.75%689.24M | 3.75%689.24M | -5.30%679.97M | -10.08%664.34M | -10.08%664.34M | -7.81%717.99M | -7.85%738.84M | --738.84M | 1.24%778.8M | 11.54%801.81M |
Liabilities | ||||||||||
Payables | 47.46%1.96M | 47.46%1.96M | -54.55%1.7M | -81.59%1.33M | -81.59%1.33M | 1,797.83%3.75M | 66.08%7.21M | --7.21M | -91.23%197.43K | 1,715.71%4.34M |
-Accounts payable | 49.85%1.94M | 49.85%1.94M | -54.78%1.68M | -81.73%1.3M | -81.73%1.3M | 2,037.90%3.72M | 70.24%7.1M | --7.1M | -92.15%173.95K | 2,257.86%4.17M |
-Other payable | -56.48%12.95K | -56.48%12.95K | -23.10%21.53K | -71.98%29.75K | -71.98%29.75K | 19.25%28K | -36.90%106.18K | --106.18K | -34.53%23.48K | 171.01%168.26K |
Long term debt and capital lease obligation | 0.00%257.1M | 0.00%257.1M | 0.00%257.1M | 0.00%257.1M | 0.00%257.1M | 0.00%257.1M | 2.63%257.1M | --257.1M | 2.63%257.1M | 6.37%250.5M |
Other liabilities | 4.84%135.52K | 4.84%135.52K | -11.08%100.44K | -17.45%129.27K | -17.45%129.27K | -57.87%112.95K | -30.95%156.6K | --156.6K | 6.91%268.13K | -51.96%226.78K |
Total liabilities | 0.25%259.19M | 0.25%259.19M | -0.79%258.9M | -2.23%258.56M | -2.23%258.56M | 1.32%260.96M | 3.68%264.46M | --264.46M | 1.80%257.57M | 7.98%255.07M |
Shareholders'equity | ||||||||||
Share capital | -0.98%532.71M | -0.98%532.71M | -0.85%539.17M | -0.90%537.99M | -0.90%537.99M | -0.28%543.8M | -0.25%542.86M | --542.86M | -0.23%545.32M | -0.34%544.23M |
-common stock | -0.98%532.71M | -0.98%532.71M | -0.85%539.17M | -0.90%537.99M | -0.90%537.99M | -0.28%543.8M | -0.25%542.86M | --542.86M | -0.23%545.32M | -0.34%544.23M |
Retained earnings | 22.35%-102.66M | 22.35%-102.66M | -36.13%-118.11M | -93.05%-132.21M | -93.05%-132.21M | -260.26%-86.76M | -2,833.57%-68.48M | ---68.48M | 20.56%-24.08M | 103.95%2.51M |
Total stockholders'equity | 5.98%430.05M | 5.98%430.05M | -7.87%421.06M | -14.46%405.78M | -14.46%405.78M | -12.32%457.03M | -13.24%474.38M | --474.38M | 0.96%521.23M | 13.27%546.74M |
Total equity | 5.98%430.05M | 5.98%430.05M | -7.87%421.06M | -14.46%405.78M | -14.46%405.78M | -12.32%457.03M | -13.24%474.38M | --474.38M | 0.96%521.23M | 13.27%546.74M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |